Jaguar Health, Inc. (JAGX) Cash flow
Market cap
$42.83M
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 5,155 | 47,494 | 584,339 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Stock-based compensation | 992,165 | 717,927 | 814,613 | 2 | 3 | 3 | 4 | 3 | 2 | 2 | 1 |
| Cash from operations | -14,315,863 | -14,413,718 | -9,824,940 | -22,730,832 | -20,456,806 | -15 | -35 | -33 | -33 | -29 | -24 |
| Capital expenditures | -23,300 | -104,207 | - | -6,527 | - | -0 | -0 | -0 | - | -0 | - |
| Cash from investing | -3,002,700 | 2 | -1,285,215 | -6,527 | - | -0 | -0 | -2 | - | -0 | -0 |
| Repurchases of common stock | - | - | - | 30 | - | - | - | - | - | - | - |
| Proceeds from issuance of term debt, net | 6 | - | - | - | - | 12 | - | - | - | - | - |
| Repayments of term debt | 1,000,000 | 2 | 2 | 2 | - | 0 | 0 | - | - | - | - |
| Cash from financing | 24 | 5 | 11 | 25 | 22 | 19 | 44 | 23 | 34 | 31 | 24 |
| Free cash flow | - | - | - | - | |||||||
| FCF margin (%) | - | - | - | - | - |